NCI?s Development of Baseline Cancer and Radiation-Related Illness Rates Relating to Nuclear Weapons Testing in the Marshall Islands

Type Journal Article - Testimony before the Committee on Resources and the Subcommittee on Asia and the Pacific of the Committee on International Relations United States House of Representatives, Wednesday
Title NCI?s Development of Baseline Cancer and Radiation-Related Illness Rates Relating to Nuclear Weapons Testing in the Marshall Islands
Author(s)
Publication (Day/Month/Year) 2005
URL http://www.t.nuclearfiles.org/menu/key-issues/nuclear-weapons/issues/health-environment/nuclear_EE73​ED4D.pdf
Abstract
Chairman Pombo and Chairman Leach, Members of the Committee on Resources and the
International Relations Subcommittee on Asia and the Pacific, thank you for the
opportunity to testify on behalf of the National Cancer Institute (NCI) of the National
Institutes of Health, an agency of the U.S. Department of Health and Human Services. I
am Andre Bouville, Ph.D., lead radiation dosimetrist with the NCI?s Division of Cancer
Epidemiology and Genetics. My testimony will describe the findings from NCI?s
October 2004 correspondence with the Senate Committee on Energy and Natural
Resources, discussed below, and will describe some of the scientific uncertainties
associated with our findings.